Search clinical trials for: Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Total 474714 results
-
University of GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedDepressive Disorder | Depression | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 VariantNetherlands
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Karl Landsteiner Institute for Systematics in General...CompletedDisorder Due Cytochrome P450 CYP2D6 VariantAustria
-
University Hospital, GenevaTerminatedDrug Effect | Drug Intolerance | Cytochrome P450 CYP2D6 Enzyme DeficiencySwitzerland
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedAnovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 VariantGermany
-
Fondation LenvalCompletedPsychotropic Drugs | Drug ResistanceFrance
-
Advocate Health CareCompletedDelirium, Cytochrome P-450 Enzyme SystemUnited States
-
University of BolognaCompletedChronic Pain | Analgesia | Opioid Use | CYP2D6 PolymorphismItaly
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPoor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantBrazil
-
Mansoura UniversityCompleted
-
Children's Mercy Hospital Kansas CityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Yonsei UniversityInje UniversityCompletedBreast Neoplasms | Antineoplastic Agents | Therapeutic Uses | Survival AnalysisKorea, Republic of
-
Lawson Health Research InstituteCompletedCytochrome P450 2D6 Ultra-rapid MetabolismCanada
-
H. Lundbeck A/SCompletedCytochrome P450 InteractionUnited Kingdom, United States
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
University Hospital, Basel, SwitzerlandCompletedCytochrome P450 CYP3A Enzyme DeficiencySwitzerland
-
University of WashingtonNational Institute of General Medical Sciences (NIGMS)Completed
-
University of Southern DenmarkOdense University HospitalTerminatedCytochrome P450 Phenotype and Genotype MetricsDenmark
-
PfizerCompletedPharmacokinetics | Cytochrome P-450 CYP2D6 | CYP3A4 Protein, HumanUnited States
-
University of WashingtonNational Institute of General Medical Sciences (NIGMS)Completed
-
California Pacific Medical Center Research InstituteChildren's Mercy Hospital Kansas CityWithdrawnMethamphetamine Metabolism, CYP2D6 GenotypeUnited States
-
GGZ CentraalZonMw: The Netherlands Organisation for Health Research and Development; Pa... and other collaboratorsCompletedCYP2D6, Psychiatric PatientsNetherlands
-
University of FloridaCompleted
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Mutual Pharmaceutical Company, Inc.CompletedHealthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoproteinUnited States
-
Janssen Research & Development, LLCCompleted
-
Korea University Anam HospitalNational Cancer Center, Korea; Korean Breast Cancer Study GroupUnknownBreast Neoplasms | Genotype | Tamoxifen | CYP2D6Korea, Republic of
-
Medical University of SilesiaCompletedOther Disorders of Muscle in Diseases Classified ElsewherePoland
-
Syntrix Biosystems, Inc.PRA Health Sciences; DF/Net Rearch; ITT Research InstituteCompleted
-
University Hospital, CaenCompleted
-
Inje UniversityCompletedHealthy Subjects | Genotype Guided(HNF4a)
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellSingapore, United States
-
University of FloridaNational Human Genome Research Institute (NHGRI)Completed
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Instituto de Investigación Hospital Universitario...CompletedAtrial Fibrillation | Venous Thromboses | Cardiac Valve DiseaseSpain
-
CTI BioPharmaPPDCompletedDrug InteractionsUnited States
-
AlexionCompletedWilson DiseaseUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Assaf-Harofeh Medical CenterUnknownAutism | Neuroleptic TreatmentIsrael
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Asan Medical CenterUnknown
-
Cancer Institute and Hospital, Chinese Academy...PfizerEnrolling by invitation
-
Western Sydney Local Health DistrictSt George Hospital, AustraliaCompletedBreast Cancer | CYP2D6 PolymorphismAustralia
-
University of Colorado, DenverNational Institute of General Medical Sciences (NIGMS)Terminated
-
Seoul National University HospitalNational Institute of Food and Drug Safety Evaluation, KoreaCompleted
-
Duke UniversityNational Human Genome Research Institute (NHGRI)Active, not recruitingDepressionUnited States
-
Rennes University HospitalMinistry of Health, FranceCompleted